Filing Details

Accession Number:
0000950170-25-099203
Form Type:
13G Filing
Publication Date:
2025-07-27 20:00:00
Filed By:
TSSP Sub-Fund HoldCo, LLC
Company:
Caris Life Sciences Inc.
Filing Date:
2025-07-28
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
TSSP Sub-Fund HoldCo, LLC 0 23,166,128 8.3%
Alan Waxman 0 24,385,399 8.8%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
TSSP Sub-Fund HoldCo, LLC
 
Signature:/s/ Joshua Peck
Name/Title:Joshua Peck, Vice President
Date:07/28/2025
 
Alan Waxman
 
Signature:/s/ Joshua Peck
Name/Title:Joshua Peck, on behalf of Alan Waxman (*)
Date:07/28/2025

Comments accompanying signature:   Joshua Peck is signing on behalf of Mr. Waxman pursuant to an authorization and designation letter dated December 31, 2024, filed herewith.
Exhibit Information

Exhibit 1 - Agreement of Joint Filing Exhibit 2 - Authorization and Designation Letter, dated December 31, 2024, by Alan Waxman (filed herewith)